Advicenne
A specialty pharmaceutical company developing treatments for rare renal diseases.
ALDVI | PA
Overview
Corporate Details
- ISIN(s):
- FR0013296746 (+1 more)
- LEI:
- 969500YT5VMEYAYODW34
- Country:
- France
- Address:
- 262 RUE DU FAUBOURG SAINT-HONORE, 75008 PARIS
- Website:
- https://advicenne.com
- Sector:
- Manufacturing
Description
Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 11:30 |
Informations privilégiées / Autres communiqués
|
French | PDF • 175.1 KB | ||
| 2025-11-04 11:30 |
Inside Information / Other news releases
|
English | PDF • 143.4 KB | ||
| 2025-09-19 18:00 |
Inside Information / News release on accounts, results
|
English | PDF • 295.8 KB | ||
| 2025-09-19 18:00 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | PDF • 325.3 KB | ||
| 2025-08-26 18:00 |
Inside Information / Other news releases
|
English | PDF • 191.1 KB | ||
| 2025-08-26 18:00 |
Informations privilégiées / Autres communiqués
|
French | PDF • 208.8 KB | ||
| 2025-07-28 07:30 |
Inside Information / Other news releases
|
English | PDF • 164.8 KB | ||
| 2025-07-28 07:30 |
Informations privilégiées / Autres communiqués
|
French | PDF • 178.7 KB | ||
| 2025-07-25 07:30 |
Inside Information / Other news releases
|
English | PDF • 177.4 KB | ||
| 2025-07-25 07:30 |
Informations privilégiées / Autres communiqués
|
French | PDF • 190.6 KB | ||
| 2025-07-21 20:52 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | PDF • 400.4 KB | ||
| 2025-07-21 20:52 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | PDF • 348.5 KB | ||
| 2025-06-30 08:00 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | PDF • 513.1 KB | ||
| 2025-06-30 08:00 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | PDF • 626.6 KB | ||
| 2025-05-16 08:00 |
Informations privilégiées / Autres communiqués
|
French | PDF • 114.8 KB |
Automate Your Workflow. Get a real-time feed of all Advicenne filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Advicenne
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Advicenne via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-04 | N/A | Other | Other | 1,452,282 | 3,499,999.62 EUR |
| 2023-10-04 | N/A | Other | Buy | 41,493 | 99,998.13 EUR |
| 2023-10-02 | N/A | Other | Other | 414,937 | 999,998.17 EUR |
| 2023-09-21 | N/A | Other | Sell | 22,336 | 22.34 EUR |
| 2023-09-15 | N/A | Other | Sell | 134,492 | 13.45 EUR |
Peer Companies
